Journey Medical Corp

Research Journey Medical Corp (DERM) on Bullrun: market cap USD 186.96M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerDERM
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryDrug Manufacturers-Specialty & Generic
• CurrencyUSD
• Market capUSD 186.96M
• Financial periodFY2025
• RevenueUSD 61.24M
• Revenue growth11.1%
• Net income-USD 11.43M
• Gross margin65.8%

Valuation Snapshot

latest market cap is USD 186.96M.

About Journey Medical Corp

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne;

Frequently asked questions

What is Journey Medical Corp's market cap?

Journey Medical Corp's market capitalization is USD 186.96M.

What does Journey Medical Corp do?

Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.